Science Current Events | Science News | Brightsurf.com
 

Wild gorillas carriers of a SIV virus close to the AIDS virus

November 14, 2006
In 2005, 40.3 million people in the world, including 25.8 million in Sub-Saharan Africa, were living with HIV. The question of the origin of HIV-1, responsible for the AIDS pandemic, has been stimulating the scientific community for many years.

Some months ago, the team of Martine Peeters, director of research at IRD, and Eric Delaporte, director of the mixed research unit UMR 145 jointly involving the IRD and the University of Montpellier 1, showed the chimpanzee subspecies living in the Congo Basin (2) to be the reservoir of HIV-1 virus group M, the source of the world pandemic and that of another, very rare variant, HIV-1 group N. However, the reservoir of the third HIV-1 group, group O which infects humans (3), remained unidentified up to now.

This team announces, in an article in the journal Nature, the discovery of a simian immunodeficiency virus (SIV) infection in wild gorillas. Samples of faeces collected from different communities of gorillas found in the remotest areas of the Cameroon tropical forest were found to contain antibodies against this virus, called SIVgor. The genetic characteristics of the virus were present again in three gorillas living more than 400 km apart. Phylogenetic analysis of SIVgor showed it to be related to HIV-1 group O found in humans, essentially in Cameroon and in neighbouring countries.

This discovery of an HIV-1 related virus in wild gorillas does not, however, call into question the fact that chimpanzees are the primary reservoir of SIV/HIV viruses that crop up again in gorillas and in humans. As Martine Peeters of the IRD says, "the viruses of groups M and N are, very clearly, the consequence of inter-species transmission from chimpanzee to humans, whereas the origin of HIV-1 group O is less apparent. It cannot be excluded that chimpanzees infected by HIV-1 group O might have contaminated humans and the gorilla independently, or that the gorilla, having been contaminated by the chimpanzee, might have contaminated humans".

This work thus opens up a Pandora's box on the questions and speculations concerning the ability of these viruses to cross over from one species to another. The main challenges facing these teams for future work will be determination of the prevalence, the geographical distribution and biology of SIV infections in these great apes, not forgetting the question of how the gorillas were contaminated. This last point remains a mystery,considered as rare.

1. UMR 145: Fran Van Heuverswijn, Cecile Neel, Florian Liegeois, Christelle Butel, Eric Delaporte and Martine Peeters jointly involving the IRD and the University of Montpellier1 University of Alabama (Beatrice Hahn and her colleagues), University of Nottingham (Paul Sharp and his colleagues) PRESICA Project of Cameroon headed by Eitel Mpoudi-Ngole.

2. Keele BF, Van Heuverswyn F, Li Y, Bailes E, Takehisa J, Santiago ML, Bibollet-Ruche F, Chen Y, Wain LV, Liegeois F, Loul S, Mpoudi Ngole E, Bienvenue Y, Delaporte E, Brookfield JF, Sharp PM, Shaw GM, Peeters M, Hahn BH. Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1. Science. 2006 , 313 : 523-6

3. Scientists have known for a long time that the Aids virus shows a very strong genetic variability. Two main types of the virus exist: HIV 1 and HIV 2. HIV 1, the most widely spread in the world, embraces three groups (M, N,O) which manifest different genetic characteristics. Within group M, the most frequent, still 9 further subtypes can be distinguished (A, B, C, D, F, G, H, J, K), genetically close yet distinct.

Institut de Recherche Pour le Développement


Related Hiv-1 Current Events and Hiv-1 News Articles


Postoperative mortality rates low among patients with HIV prescribed ART
ostoperative mortality rates were low among patients infected with the human immunodeficiency virus (HIV) who are receiving antiretroviral therapy (ART), and those mortality rates were influenced as much by age and poor nutritional status as CD4 cell counts.

Genetically engineered antibody-based molecules show enhanced HIV-fighting abilities
Capitalizing on a new insight into HIV's strategy for evading antibodies--proteins produced by the immune system to identify and wipe out invading objects such as viruses--Caltech researchers have developed antibody-based molecules that are more than 100 times better than our bodies' own defenses at binding to and neutralizing HIV, when tested in vitro.

LSU Health New Orleans identifies toxic Ebola protein fragment
William Gallaher, PhD, Emeritus Professor of Microbiology, Immunology & Parasitology at LSU Health New Orleans School of Medicine, has discovered a fragment of an Ebola virus protein that is toxic to cells and may contribute to infection and illness.

Progress toward an HIV cure highlighted in special issue of AIDS Research and Human Retroviruses
A cure for HIV/AIDS is the ultimate goal of rapidly advancing research involving diverse and innovative approaches.

Dolutegravir/abacavir/lamivudine: Considerable added benefit for some adults with HIV
Since September 2014, the fixed-dose combination of dolutegravir/abacavir/lamivudine (trade name Triumeq) has been approved for human immunodeficiency virus (HIV) infected adults and adolescents above 12 years of age.

CWRU researchers discover byproducts from bacteria awaken dormant T-cells and HIV viruses
Dental and medical researchers from Case Western Reserve University found another reason to treat periodontal disease as soon as possible.

Molecules seen binding to HIV-1's protective capsule, blocking infection
Imagine a suitcase on a bumpy ride. With enough jostling it opens, spilling clothes everywhere. Similarly awkward, the suitcase locks may jam and not open at the destination.

Cell-associated HIV mucosal transmission: The neglected pathway
Dr. Deborah Anderson from Boston University School of Medicine (BUSM) and her colleagues are challenging dogma about the transmission of the human immunodeficiency virus type 1 (HIV-1).

Narrow time window exists to start HIV therapy, study shows
HIV-1-infected U.S. military members and beneficiaries treated with antiretroviral therapy (ART) soon after infection were half as likely to develop AIDS and were more likely to reconstitute their immune-fighting CD4+ T-cells to normal levels, researchers reported Nov. 24 in JAMA Internal Medicine.

New study reveals why some people may be immune to HIV-1
Doctors have long been mystified as to why HIV-1 rapidly sickens some individuals, while in others the virus has difficulties gaining a foothold.
More Hiv-1 Current Events and Hiv-1 News Articles

HIV-1 Integrase: Mechanism and Inhibitor Design

HIV-1 Integrase: Mechanism and Inhibitor Design
by Nouri Neamati (Editor), Binghe Wang (Editor)


This book comprehensively covers the mechanisms of action and inhibitor design for HIV-1 integrase. It serves as a resource for scientists facing challenging drug design issues and researchers in antiviral drug discovery. Despite numerous review articles and isolated book chapters dealing with HIV-1 integrase, there has not been a single source for those working to devise anti-AIDS drugs against this promising target. But this book fills that gap and offers a valuable introduction to the field for the interdisciplinary scientists who will need to work together to design drugs that target HIV-1 integrase.

HIV Won't Kill Me: Encouragement eBook (Josh Fights HIV Stigma 1)

HIV Won't Kill Me: Encouragement eBook (Josh Fights HIV Stigma 1)
by imstilljosh.com


Learning you are HIV-positive is a pretty scary time in a person's life. Josh Robbins found out that he was living with HIV in the beginning of 2012 and started an online journey encouraging others that are living with the virus to keep their mind and spirit in a good place. His main method of offering that encouragement? By sharing images. This coffee-table formatted book shares the images that Josh Robbins of imstilljosh.com uses to fight HIV stigma.

The First Year: HIV: An Essential Guide for the Newly Diagnosed

The First Year: HIV: An Essential Guide for the Newly Diagnosed
by Brett Grodeck (Author), M.D. Daniel S. Berger M.D. (Foreword)


This supportive resource explores the next generation of HIV/AIDS drugs and also includes new research on HIV and crystal meth, as well as new insights for the hardest hit population — African Americans.

A Loving Testimony: Remembering Loved Ones Lost to AIDS

A Loving Testimony: Remembering Loved Ones Lost to AIDS
by Leslea Newman (Editor)




HIV-1: Molecular Biology and Pathogenesis: Viral Mechanisms, 2nd Edition (Advances in Pharmacology, Vol. 55)

HIV-1: Molecular Biology and Pathogenesis: Viral Mechanisms, 2nd Edition (Advances in Pharmacology, Vol. 55)
by Kuan-Teh Jeang (Editor), J. Thomas August (Editor), Ferid Murad (Editor)


This volume covers the latest advances in the mechanisms of pathogenesis of the HIV-1 virus on target cells. Its companion volume, Advances in Pharmacology 56, shows how new developments in understanding the virus translate to the clinical setting.

HIV Hoax: I will pay anyone ONE Million Dollars to prove me wrong

HIV Hoax: I will pay anyone ONE Million Dollars to prove me wrong
by Brett Salisbury (Author), Dr. Lawrence Cohen M.D. PHD (Author), Dr John Mack PHD (Author)


Mass Media has a terrible impact on those who lack guidance. This includes you. You were born and raised in the Television world. CNN and FOX news have blinded you. You are a victim. We understand that. We are here to help you. The focus of this book will be on HIV, AIDS and Ebola. The game is over. We will now enlighten you with truth.

HIV Essentials 2014

HIV Essentials 2014
by Paul E. Sax (Author), Calvin J. Cohen (Author), Daniel R. Kuritzkes (Author)


The world's leading experts provide all the 'essentials' needed to manage HIV patients in the office, on the ward, and in the ICU. Completely revised and updated, HIV Essentials 2014 incorporates the latest clinical guidelines into a step-by-step guide to the diagnosis, evaluation, management, and prevention of HIV infection and its complications. Topics include: opportunistic infections and other HIV complications, treatment of HIV and pregnancy, antiretroviral drug summaries, post-exposure prophylaxis, as well as commercially available dosage forms for all ARVs.

First Aid Q&A for the USMLE Step 1, Third Edition (First Aid USMLE)

First Aid Q&A for the USMLE Step 1, Third Edition (First Aid USMLE)
by Tao Le (Author), James A. Feinstein (Author), Mark W. Ball (Author), Annie Dude (Author), Rebecca L. Hoffman (Author), Mark Robert Jensen (Author), Kimberly Kallianos (Author), Cesar Raudel Padilla (Author), Lauren Rothkopf (Author), James Yeh (Author)


1,000 questions and answers prepare you for the USMLE Step 1! The only comprehensive Q&A review for the USMLE Step directly linked to high-yield facts from Dr. Le's First Aid for the USMLE Step 1, this essential study guide offers 1000 board-style questions and answers, easy-to-navigate, high yield explanations for correct and incorrect answers, and more than 350 accompanying images. Features:
1000 board-style questions and answers -- reviewed and approved -- by students who just aced the exam Detailed explanations for both right and wrong answers - with letter options in boldface for at-a-glance review Chapters keyed to Dr. Le's First Aid for the USMLE Step 1 so you can simultaneously review questions and high-yield facts 130+ high-yield images, diagrams, and tables One...

Living With HIV and AIDS: Prevention, Healing Symptoms, the Newest Treatments, and Possible Cures (Health Book 1)

Living With HIV and AIDS: Prevention, Healing Symptoms, the Newest Treatments, and Possible Cures (Health Book 1)


The Definitive Guide To HIV/AIDS
Living with HIV or AIDS can be extremely difficult, not only because of the stigma but because of the medical treatments which, while they are advancing every day, have a ways to go. This book tells you everything to know about HIV/AIDS, including everything from infection to the different stages of the disease to the innovative new treatments that are starting to become available (some as new as March 2014!).

"It is bad enough that people are dying of AIDS, but no one should die of ignorance." - Elizabeth Taylor

Here Is A Preview Of What You'll Learn...
How HIV and AIDS work in the bodyHow infection occurs, and several strategies at preventionManaging symptoms of HIV, and preventing it from turning into AIDSModern...

© 2015 BrightSurf.com